Therefore, inactivating SDH mutations in specific cancer subsets, or down-regulation of SDH activity by TRAP1 in a wider number of tumor types, might contribute to the neoplastic process not only by stabilizing HIF1, but also by changing the redox equilibrium of malignant cells [15, 17, 23]. The gene discussed is HIF1A; the disease is cancer.